Back to top
Top
DERep Home Page

["Patient Characteristic, Sex": "ONC Administrative Sex"]

Performance/Reporting Period
2022
Value Set Description from VSAC
Clinical Focus: Gender identity restricted to only Male and Female used in administrative situations requiring a restriction to these two categories.
Data Element Scope: Gender
Inclusion Criteria: Male and Female only.
Exclusion Criteria: Any gender identity that is not male or female.

Constrained to codes in the Patient Characteristic, Sex: ONC Administrative Sex value set (2.16.840.1.113762.1.4.1)

QDM Datatype and Definition (QDM Version 5.5 Guidance Update)

"Patient Characteristic, Sex"

Data elements that meet criteria using this datatype should document that the patient's sex matches the QDM category and its corresponding value set.

Timing: Birth (administrative) sex does not have a specific timing.

eCQMs using this data element:
CMS133v10 - Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS142v10 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS117v10 - Childhood Immunization Status
CMS105v10 - Discharged on Statin Medication
CMS349v4 - HIV Screening
CMS645v5 - Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS249v4 - Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
CMS71v11 - Anticoagulation Therapy for Atrial Fibrillation/Flutter
CMS131v10 - Diabetes: Eye Exam
CMS90v11 - Functional Status Assessments for Heart Failure
CMS75v10 - Children Who Have Dental Decay or Cavities
CMS111v10 - Median Admit Decision Time to ED Departure Time for Admitted Patients
CMS156v10 - Use of High-Risk Medications in Older Adults
CMS135v10 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS139v10 - Falls: Screening for Future Fall Risk
CMS144v10 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS127v10 - Pneumococcal Vaccination Status for Older Adults
CMS129v11 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS506v4 - Safe Use of Opioids - Concurrent Prescribing
CMS125v10 - Breast Cancer Screening
CMS146v10 - Appropriate Testing for Pharyngitis
CMS137v10 - Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS154v10 - Appropriate Treatment for Upper Respiratory Infection (URI)
CMS22v10 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS2v11 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS69v10 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS646v2 - Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
CMS56v10 - Functional Status Assessment for Total Hip Replacement
CMS72v10 - Antithrombotic Therapy By End of Hospital Day 2
CMS108v10 - Venous Thromboembolism Prophylaxis
CMS104v10 - Discharged on Antithrombotic Therapy
CMS143v10 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS771v3 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
CMS165v10 - Controlling High Blood Pressure
CMS177v10 - Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS122v10 - Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS130v10 - Colorectal Cancer Screening
CMS153v10 - Chlamydia Screening for Women
CMS9v10 - Exclusive Breast Milk Feeding
CMS149v10 - Dementia: Cognitive Assessment
CMS134v10 - Diabetes: Medical Attention for Nephropathy
CMS157v10 - Oncology: Medical and Radiation - Pain Intensity Quantified
CMS529v2 - Core Clinical Data Elements for the Hybrid Hospital-Wide Readmission (HWR) Measure with Claims and Electronic Health Record Data
CMS145v10 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)
CMS138v10 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS161v10 - Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS66v10 - Functional Status Assessment for Total Knee Replacement
CMS50v10 - Closing the Referral Loop: Receipt of Specialist Report
CMS74v11 - Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS68v11 - Documentation of Current Medications in the Medical Record
CMS190v10 - Intensive Care Unit Venous Thromboembolism Prophylaxis
CMS159v10 - Depression Remission at Twelve Months
CMS124v10 - Cervical Cancer Screening
CMS155v10 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents
CMS128v10 - Anti-depressant Medication Management
CMS136v11 - Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS347v5 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS147v11 - Preventive Care and Screening: Influenza Immunization
Last Updated: Jul 08, 2021